Gene therapy for pediatric hearing loss
09-10, 14:00–14:30 (Europe/Istanbul), Pediatric Otolaryngology 2

12- Gene therapy for pediatric hearing loss

Speaker Speaker

Hospital Practitioner, ENT and Head and Neck Surgery, Otology, Children's Audiology

Head of the Ped. Audiophonology and Cochlear Implant Unit - Necker-Enfants malades Hospital, Paris

Member of the UMRS 1120 Unit, and of the Center for Rare Diseases-Genetic Deafness

Career

1999--: MD PHD, ENT and Head and Neck Surgery, Armand-Trousseau Children's Hospital, and at Necker-Enfants malades Paris, since 2012

2003---: Head of the Pediatric Audiophonology and Cochlear Implant Department, in Armand-Trousseau Children's Hospital and in Necker Enfants malades

2020---: Head of the Audiology Research Platform at Necker

2022-2024: President of the French Association of Pediatric ENT (AFOP)

2024---: Board member - French Society of Audiology 

Academic activities

Head of the Pediatric Audiophonology and Cochlear Implant Uni

Head of the Audiology Research Platform at Necker

 Otologic surgery, cochlear implant surgery

Major grants

·       2008-2009: National PHRC co-investigator: study on the cost of cochlear implants in France.

·       2015-2019: Principal Investigator for Bi-center clinical study: CNRS APHP – Analysis of the development of temporal areas by fNIRS

·       2017-2019: ISLODA Co-Investigator: Bi-center study (PHRIC) – Impact of the use of LENA in the rehabilitation of the implanted child

·       2017-2021: WP1 RHU- Light4Death (Research on Deaf Patients with Usher Syndrome)

·       2019-2025: RHU4 Project Manager - Audinnove

·       2025-2027: Project leader and principal investigator PHRC Asymic ped

·       2024- : Scientific Lead and Principal Investigator -  Audiogene- Gene Therapy Study

Conference organization

OTOFORUM 2027, Paris, France

This speaker also appears in: